Cystic Fibrosis (CF) Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Cystic Fibrosis (CF) Therapeutics Market is anticipated to register at a CAGR of nearly 9% during the forecast period 2022-2028.

Cystic fibrosis is an inherited disorder that primarily affects the lungs and other parts of the body, such as the pancreas, liver, and kidneys. It is caused by a mutation in the cystic fibrosis transmembrane conduction regulator (CFTR) gene. This gene is located on chromosome 7 and is responsible for the regulation of sweat, mucus, and body secretions. However, mutations in this gene lead to the absence of CFTR activity, which in turn results in loss of chloride and alters protein structure. Patients experience difficulty breathing, mucus formation, fatty stools, and difficulty in passage of the pancreas, bile ducts, intestines, and salivary glands. Cystic fibrosis is diagnosed through sweat testing and genetic testing. Physical therapy is used to treat cystic fibrosis, which helps reduce mucus formation and fights organ infections. Treatment of cystic fibrosis also includes the use of drugs such as Pulmozyme and Kalydeco. These drugs may be administered to patients by various routes, such as oral and inhalation.

Market Segments

By Drug Class

• Pancreatic Enzyme Supplements
• Mucolytics
• Bronchodilators
• CFTR Modulators
• Antibiotics
• Others

By Type

• Small Molecule Drugs
• Biologics

Key Players

• F. Hoffmann-La Roche AG
• Novartis AG
• Gilead Sciences, Inc.
• Vertex Pharmaceuticals Incorporated
• AbbVie Inc.
• GlaxoSmithKline Plc.
• Teva Pharmaceutical Industries Ltd.
• Allergan plc
• Pharmaxis Ltd
• Mylan N.V

Scope of the Report

The research study analyzes the global Cystic Fibrosis (CF) Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Cystic Fibrosis (CF) Therapeutics Market Report

1. What was the Cystic Fibrosis (CF) Therapeutics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Cystic Fibrosis (CF) Therapeutics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Cystic Fibrosis (CF) Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.